The global Pharma and Health Care market size was valued at USD 1281950 million in 2022 and is forecast to a readjusted size of USD 1667520 million by 2029 with a CAGR of 3.8% during review period.
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician. In this report, we mainly study the pharma and healthcare product.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%. Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
This report is a detailed and comprehensive analysis for global Pharma and Health Care market. Both quantitative and qualitative analyses are presented by company, by region & country, by Format and by Prescription. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharma and Health Care market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharma and Health Care market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharma and Health Care market size and forecasts, by Format and by Prescription, in consumption value ($ Million), 2018-2029
Global Pharma and Health Care market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharma and Health Care
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharma and Health Care market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Bottle
Blister
Others
OTC Drugs
Prescription Drugs
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Pharma and Health Care product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharma and Health Care, with revenue, gross margin and global market share of Pharma and Health Care from 2018 to 2023.
Chapter 3, the Pharma and Health Care competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Format and application, with consumption value and growth rate by Format, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharma and Health Care market forecast, by regions, format and prescription, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharma and Health Care.
Chapter 13, to describe Pharma and Health Care research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Pharma and Health Care
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharma and Health Care by Format
1.3.1 Overview: Global Pharma and Health Care Market Size by Format: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharma and Health Care Consumption Value Market Share by Format in 2022
1.3.3 Bottle
1.3.4 Blister
1.3.5 Others
1.4 Global Pharma and Health Care Market by Prescription
1.4.1 Overview: Global Pharma and Health Care Market Size by Prescription: 2018 Versus 2022 Versus 2029
1.4.2 OTC Drugs
1.4.3 Prescription Drugs
1.5 Global Pharma and Health Care Market Size & Forecast
1.6 Global Pharma and Health Care Market Size and Forecast by Region
1.6.1 Global Pharma and Health Care Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharma and Health Care Market Size by Region, (2018-2029)
1.6.3 North America Pharma and Health Care Market Size and Prospect (2018-2029)
1.6.4 Europe Pharma and Health Care Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharma and Health Care Market Size and Prospect (2018-2029)
1.6.6 South America Pharma and Health Care Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharma and Health Care Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Pharma and Health Care Product and Solutions
2.1.4 Johnson & Johnson Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Pharma and Health Care Product and Solutions
2.2.4 Novartis Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Pharma and Health Care Product and Solutions
2.3.4 Roche Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments and Future Plans
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Pharma and Health Care Product and Solutions
2.4.4 AbbVie Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AbbVie Recent Developments and Future Plans
2.5 Merck & Co.
2.5.1 Merck & Co. Details
2.5.2 Merck & Co. Major Business
2.5.3 Merck & Co. Pharma and Health Care Product and Solutions
2.5.4 Merck & Co. Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merck & Co. Recent Developments and Future Plans
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business
2.6.3 Bristol Myers Squibb Pharma and Health Care Product and Solutions
2.6.4 Bristol Myers Squibb Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol Myers Squibb Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Pharma and Health Care Product and Solutions
2.7.4 GlaxoSmithKline Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Pharma and Health Care Product and Solutions
2.8.4 Pfizer Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Pharma and Health Care Product and Solutions
2.9.4 Sanofi Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Pharma and Health Care Product and Solutions
2.10.4 Takeda Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Takeda Recent Developments and Future Plans
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Pharma and Health Care Product and Solutions
2.11.4 AstraZeneca Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AstraZeneca Recent Developments and Future Plans
2.12 Bayer
2.12.1 Bayer Details
2.12.2 Bayer Major Business
2.12.3 Bayer Pharma and Health Care Product and Solutions
2.12.4 Bayer Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bayer Recent Developments and Future Plans
2.13 Eli Lilly & Co.
2.13.1 Eli Lilly & Co. Details
2.13.2 Eli Lilly & Co. Major Business
2.13.3 Eli Lilly & Co. Pharma and Health Care Product and Solutions
2.13.4 Eli Lilly & Co. Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Eli Lilly & Co. Recent Developments and Future Plans
2.14 Gilead Sciences
2.14.1 Gilead Sciences Details
2.14.2 Gilead Sciences Major Business
2.14.3 Gilead Sciences Pharma and Health Care Product and Solutions
2.14.4 Gilead Sciences Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Gilead Sciences Recent Developments and Future Plans
2.15 Amgen
2.15.1 Amgen Details
2.15.2 Amgen Major Business
2.15.3 Amgen Pharma and Health Care Product and Solutions
2.15.4 Amgen Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Amgen Recent Developments and Future Plans
2.16 Novo Nordisk
2.16.1 Novo Nordisk Details
2.16.2 Novo Nordisk Major Business
2.16.3 Novo Nordisk Pharma and Health Care Product and Solutions
2.16.4 Novo Nordisk Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Novo Nordisk Recent Developments and Future Plans
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business
2.17.3 Teva Pharma and Health Care Product and Solutions
2.17.4 Teva Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Teva Recent Developments and Future Plans
2.18 Boehringer Ingelheim
2.18.1 Boehringer Ingelheim Details
2.18.2 Boehringer Ingelheim Major Business
2.18.3 Boehringer Ingelheim Pharma and Health Care Product and Solutions
2.18.4 Boehringer Ingelheim Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Boehringer Ingelheim Recent Developments and Future Plans
2.19 Biogen
2.19.1 Biogen Details
2.19.2 Biogen Major Business
2.19.3 Biogen Pharma and Health Care Product and Solutions
2.19.4 Biogen Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Biogen Recent Developments and Future Plans
2.20 Astellas
2.20.1 Astellas Details
2.20.2 Astellas Major Business
2.20.3 Astellas Pharma and Health Care Product and Solutions
2.20.4 Astellas Pharma and Health Care Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Astellas Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharma and Health Care Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharma and Health Care by Company Revenue
3.2.2 Top 3 Pharma and Health Care Players Market Share in 2022
3.2.3 Top 6 Pharma and Health Care Players Market Share in 2022
3.3 Pharma and Health Care Market: Overall Company Footprint Analysis
3.3.1 Pharma and Health Care Market: Region Footprint
3.3.2 Pharma and Health Care Market: Company Product Type Footprint
3.3.3 Pharma and Health Care Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Format
4.1 Global Pharma and Health Care Consumption Value and Market Share by Format (2018-2023)
4.2 Global Pharma and Health Care Market Forecast by Format (2024-2029)
5 Market Size Segment by Prescription
5.1 Global Pharma and Health Care Consumption Value Market Share by Prescription (2018-2023)
5.2 Global Pharma and Health Care Market Forecast by Prescription (2024-2029)
6 North America
6.1 North America Pharma and Health Care Consumption Value by Format (2018-2029)
6.2 North America Pharma and Health Care Consumption Value by Prescription (2018-2029)
6.3 North America Pharma and Health Care Market Size by Country
6.3.1 North America Pharma and Health Care Consumption Value by Country (2018-2029)
6.3.2 United States Pharma and Health Care Market Size and Forecast (2018-2029)
6.3.3 Canada Pharma and Health Care Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharma and Health Care Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Pharma and Health Care Consumption Value by Format (2018-2029)
7.2 Europe Pharma and Health Care Consumption Value by Prescription (2018-2029)
7.3 Europe Pharma and Health Care Market Size by Country
7.3.1 Europe Pharma and Health Care Consumption Value by Country (2018-2029)
7.3.2 Germany Pharma and Health Care Market Size and Forecast (2018-2029)
7.3.3 France Pharma and Health Care Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharma and Health Care Market Size and Forecast (2018-2029)
7.3.5 Russia Pharma and Health Care Market Size and Forecast (2018-2029)
7.3.6 Italy Pharma and Health Care Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Pharma and Health Care Consumption Value by Format (2018-2029)
8.2 Asia-Pacific Pharma and Health Care Consumption Value by Prescription (2018-2029)
8.3 Asia-Pacific Pharma and Health Care Market Size by Region
8.3.1 Asia-Pacific Pharma and Health Care Consumption Value by Region (2018-2029)
8.3.2 China Pharma and Health Care Market Size and Forecast (2018-2029)
8.3.3 Japan Pharma and Health Care Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharma and Health Care Market Size and Forecast (2018-2029)
8.3.5 India Pharma and Health Care Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharma and Health Care Market Size and Forecast (2018-2029)
8.3.7 Australia Pharma and Health Care Market Size and Forecast (2018-2029)
9 South America
9.1 South America Pharma and Health Care Consumption Value by Format (2018-2029)
9.2 South America Pharma and Health Care Consumption Value by Prescription (2018-2029)
9.3 South America Pharma and Health Care Market Size by Country
9.3.1 South America Pharma and Health Care Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharma and Health Care Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharma and Health Care Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Pharma and Health Care Consumption Value by Format (2018-2029)
10.2 Middle East & Africa Pharma and Health Care Consumption Value by Prescription (2018-2029)
10.3 Middle East & Africa Pharma and Health Care Market Size by Country
10.3.1 Middle East & Africa Pharma and Health Care Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharma and Health Care Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharma and Health Care Market Size and Forecast (2018-2029)
10.3.4 UAE Pharma and Health Care Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Pharma and Health Care Market Drivers
11.2 Pharma and Health Care Market Restraints
11.3 Pharma and Health Care Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Pharma and Health Care Industry Chain
12.2 Pharma and Health Care Upstream Analysis
12.3 Pharma and Health Care Midstream Analysis
12.4 Pharma and Health Care Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Pharma and Health Care Consumption Value by Format, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharma and Health Care Consumption Value by Prescription, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharma and Health Care Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharma and Health Care Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 6. Johnson & Johnson Major Business
Table 7. Johnson & Johnson Pharma and Health Care Product and Solutions
Table 8. Johnson & Johnson Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Johnson & Johnson Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Pharma and Health Care Product and Solutions
Table 13. Novartis Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Roche Company Information, Head Office, and Major Competitors
Table 16. Roche Major Business
Table 17. Roche Pharma and Health Care Product and Solutions
Table 18. Roche Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Roche Recent Developments and Future Plans
Table 20. AbbVie Company Information, Head Office, and Major Competitors
Table 21. AbbVie Major Business
Table 22. AbbVie Pharma and Health Care Product and Solutions
Table 23. AbbVie Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AbbVie Recent Developments and Future Plans
Table 25. Merck & Co. Company Information, Head Office, and Major Competitors
Table 26. Merck & Co. Major Business
Table 27. Merck & Co. Pharma and Health Care Product and Solutions
Table 28. Merck & Co. Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Merck & Co. Recent Developments and Future Plans
Table 30. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 31. Bristol Myers Squibb Major Business
Table 32. Bristol Myers Squibb Pharma and Health Care Product and Solutions
Table 33. Bristol Myers Squibb Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bristol Myers Squibb Recent Developments and Future Plans
Table 35. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline Pharma and Health Care Product and Solutions
Table 38. GlaxoSmithKline Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GlaxoSmithKline Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Pharma and Health Care Product and Solutions
Table 43. Pfizer Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Sanofi Company Information, Head Office, and Major Competitors
Table 46. Sanofi Major Business
Table 47. Sanofi Pharma and Health Care Product and Solutions
Table 48. Sanofi Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sanofi Recent Developments and Future Plans
Table 50. Takeda Company Information, Head Office, and Major Competitors
Table 51. Takeda Major Business
Table 52. Takeda Pharma and Health Care Product and Solutions
Table 53. Takeda Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Takeda Recent Developments and Future Plans
Table 55. AstraZeneca Company Information, Head Office, and Major Competitors
Table 56. AstraZeneca Major Business
Table 57. AstraZeneca Pharma and Health Care Product and Solutions
Table 58. AstraZeneca Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. AstraZeneca Recent Developments and Future Plans
Table 60. Bayer Company Information, Head Office, and Major Competitors
Table 61. Bayer Major Business
Table 62. Bayer Pharma and Health Care Product and Solutions
Table 63. Bayer Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Bayer Recent Developments and Future Plans
Table 65. Eli Lilly & Co. Company Information, Head Office, and Major Competitors
Table 66. Eli Lilly & Co. Major Business
Table 67. Eli Lilly & Co. Pharma and Health Care Product and Solutions
Table 68. Eli Lilly & Co. Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Eli Lilly & Co. Recent Developments and Future Plans
Table 70. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 71. Gilead Sciences Major Business
Table 72. Gilead Sciences Pharma and Health Care Product and Solutions
Table 73. Gilead Sciences Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Gilead Sciences Recent Developments and Future Plans
Table 75. Amgen Company Information, Head Office, and Major Competitors
Table 76. Amgen Major Business
Table 77. Amgen Pharma and Health Care Product and Solutions
Table 78. Amgen Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Amgen Recent Developments and Future Plans
Table 80. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 81. Novo Nordisk Major Business
Table 82. Novo Nordisk Pharma and Health Care Product and Solutions
Table 83. Novo Nordisk Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Novo Nordisk Recent Developments and Future Plans
Table 85. Teva Company Information, Head Office, and Major Competitors
Table 86. Teva Major Business
Table 87. Teva Pharma and Health Care Product and Solutions
Table 88. Teva Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Teva Recent Developments and Future Plans
Table 90. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 91. Boehringer Ingelheim Major Business
Table 92. Boehringer Ingelheim Pharma and Health Care Product and Solutions
Table 93. Boehringer Ingelheim Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Boehringer Ingelheim Recent Developments and Future Plans
Table 95. Biogen Company Information, Head Office, and Major Competitors
Table 96. Biogen Major Business
Table 97. Biogen Pharma and Health Care Product and Solutions
Table 98. Biogen Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Biogen Recent Developments and Future Plans
Table 100. Astellas Company Information, Head Office, and Major Competitors
Table 101. Astellas Major Business
Table 102. Astellas Pharma and Health Care Product and Solutions
Table 103. Astellas Pharma and Health Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Astellas Recent Developments and Future Plans
Table 105. Global Pharma and Health Care Revenue (USD Million) by Players (2018-2023)
Table 106. Global Pharma and Health Care Revenue Share by Players (2018-2023)
Table 107. Breakdown of Pharma and Health Care by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Pharma and Health Care, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 109. Head Office of Key Pharma and Health Care Players
Table 110. Pharma and Health Care Market: Company Product Type Footprint
Table 111. Pharma and Health Care Market: Company Product Application Footprint
Table 112. Pharma and Health Care New Market Entrants and Barriers to Market Entry
Table 113. Pharma and Health Care Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Pharma and Health Care Consumption Value (USD Million) by Format (2018-2023)
Table 115. Global Pharma and Health Care Consumption Value Share by Format (2018-2023)
Table 116. Global Pharma and Health Care Consumption Value Forecast by Format (2024-2029)
Table 117. Global Pharma and Health Care Consumption Value by Prescription (2018-2023)
Table 118. Global Pharma and Health Care Consumption Value Forecast by Prescription (2024-2029)
Table 119. North America Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
Table 120. North America Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
Table 121. North America Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
Table 122. North America Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
Table 123. North America Pharma and Health Care Consumption Value by Country (2018-2023) & (USD Million)
Table 124. North America Pharma and Health Care Consumption Value by Country (2024-2029) & (USD Million)
Table 125. Europe Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
Table 126. Europe Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
Table 127. Europe Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
Table 128. Europe Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
Table 129. Europe Pharma and Health Care Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Pharma and Health Care Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
Table 132. Asia-Pacific Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
Table 133. Asia-Pacific Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
Table 134. Asia-Pacific Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
Table 135. Asia-Pacific Pharma and Health Care Consumption Value by Region (2018-2023) & (USD Million)
Table 136. Asia-Pacific Pharma and Health Care Consumption Value by Region (2024-2029) & (USD Million)
Table 137. South America Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
Table 138. South America Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
Table 139. South America Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
Table 140. South America Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
Table 141. South America Pharma and Health Care Consumption Value by Country (2018-2023) & (USD Million)
Table 142. South America Pharma and Health Care Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Middle East & Africa Pharma and Health Care Consumption Value by Format (2018-2023) & (USD Million)
Table 144. Middle East & Africa Pharma and Health Care Consumption Value by Format (2024-2029) & (USD Million)
Table 145. Middle East & Africa Pharma and Health Care Consumption Value by Prescription (2018-2023) & (USD Million)
Table 146. Middle East & Africa Pharma and Health Care Consumption Value by Prescription (2024-2029) & (USD Million)
Table 147. Middle East & Africa Pharma and Health Care Consumption Value by Country (2018-2023) & (USD Million)
Table 148. Middle East & Africa Pharma and Health Care Consumption Value by Country (2024-2029) & (USD Million)
Table 149. Pharma and Health Care Raw Material
Table 150. Key Suppliers of Pharma and Health Care Raw Materials
List of Figures
Figure 1. Pharma and Health Care Picture
Figure 2. Global Pharma and Health Care Consumption Value by Format, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharma and Health Care Consumption Value Market Share by Format in 2022
Figure 4. Bottle
Figure 5. Blister
Figure 6. Others
Figure 7. Global Pharma and Health Care Consumption Value by Format, (USD Million), 2018 & 2022 & 2029
Figure 8. Pharma and Health Care Consumption Value Market Share by Prescription in 2022
Figure 9. OTC Drugs Picture
Figure 10. Prescription Drugs Picture
Figure 11. Global Pharma and Health Care Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pharma and Health Care Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Pharma and Health Care Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Pharma and Health Care Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Pharma and Health Care Consumption Value Market Share by Region in 2022
Figure 16. North America Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Pharma and Health Care Revenue Share by Players in 2022
Figure 22. Pharma and Health Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Pharma and Health Care Market Share in 2022
Figure 24. Global Top 6 Players Pharma and Health Care Market Share in 2022
Figure 25. Global Pharma and Health Care Consumption Value Share by Format (2018-2023)
Figure 26. Global Pharma and Health Care Market Share Forecast by Format (2024-2029)
Figure 27. Global Pharma and Health Care Consumption Value Share by Prescription (2018-2023)
Figure 28. Global Pharma and Health Care Market Share Forecast by Prescription (2024-2029)
Figure 29. North America Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
Figure 30. North America Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
Figure 31. North America Pharma and Health Care Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
Figure 36. Europe Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
Figure 37. Europe Pharma and Health Care Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 39. France Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
Figure 44. Asia-Pacific Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
Figure 45. Asia-Pacific Pharma and Health Care Consumption Value Market Share by Region (2018-2029)
Figure 46. China Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 49. India Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
Figure 53. South America Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
Figure 54. South America Pharma and Health Care Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Pharma and Health Care Consumption Value Market Share by Format (2018-2029)
Figure 58. Middle East and Africa Pharma and Health Care Consumption Value Market Share by Prescription (2018-2029)
Figure 59. Middle East and Africa Pharma and Health Care Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Pharma and Health Care Consumption Value (2018-2029) & (USD Million)
Figure 63. Pharma and Health Care Market Drivers
Figure 64. Pharma and Health Care Market Restraints
Figure 65. Pharma and Health Care Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Pharma and Health Care in 2022
Figure 68. Manufacturing Process Analysis of Pharma and Health Care
Figure 69. Pharma and Health Care Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
